Aims and difficulties of targeting Simon ChowdhuryPeter G. Harper Editorial 11 April 2006 Pages: 69 - 70
Differential expression of EGFR and TGFα in VHL-mutated renal cell carcinomas of the clear cell type: implications for targeted therapeutic approaches Derek AtkinsDetlef RohdeStephan Störkel Original Research 08 April 2006 Pages: 71 - 78
Convection-enhanced delivery of liposomal doxorubicin in intracranial brain tumor xenografts Yoji YamashitaRyuta SaitoKrystof S. Bankiewicz Original Research 21 March 2006 Pages: 79 - 85
Effect of paclitaxel on vascular endothelial growth factor (VEGF) and interleukin (IL)-8 in serum of patients with recurrent ovarian cancer: a comparison of weekly vs triweekly regimens Keiko SaitoYoshihiro KikuchiKenichi Furuya Original Research 04 April 2006 Pages: 86 - 89
Improving drug penetration in tumors by targeting tumor vascularization Ferdy J. Lejeune Review 11 April 2006 Pages: 90 - 96
Comparison of different techniques and markers in the detection of neuroblastoma cells in bone marrow and peripheral blood samples: are they really equivalent? Maria Valeria Corrias Perspectives 04 April 2006 Pages: 97 - 99
Folliculitis and perionyxis associated with the EGFR inhibitor erlotinib C. RobertJ. C. SoriaO. Chosidow Day-to-day Practice 06 April 2006 Pages: 100 - 103
Hypertension and targeted therapy Simon ChowdhuryJames F. SpicerPeter G. Harper Day-to-day Practice 12 April 2006 Pages: 104 - 108
ASCO GI 2006, San Francisco, 26–28 January 2006 Emmanuel Mitry Meeting Report 06 April 2006 Pages: 109 - 111
